
Related news and events
Admissions and credentials
New York
Experience
Sanity Closes $85 Million Series C
May 8, 2025
Cooley advised Sanity, a content management system that helps build dynamic, content-rich experiences and streamline content workflows, on its $85 Million Series C.
Related contacts
Related Practices & Industries
Datadog Acquires Eppo
May 7, 2025
Cooley advised Datadog (Nasdaq: DDOG), a monitoring and security platform for cloud applications, on its acquisition of Eppo, a feature flagging and experimentation platform that will tightly integrate with Datadog’s existing product analytics suite.
Related contacts
Related Practices & Industries
Cerberus Announces Landmark Investment in Aquatech
April 3, 2025
Cooley advised Cerberus Capital Management, a global leader in alternative investing with approximately $65 billion in assets across complementary credit, real estate and private equity strategies, on its growth investment in Aquatech, a global leader in water technology and services for industrial and infrastructure markets.
Related contacts
Related Practices & Industries
Lovable Announces $15 Million Pre-Series A
February 25, 2025
Cooley advised Lovable Labs, a Sweden-based artificial intelligence startup, on its $15 million pre-Series A financing round. The round was led by Creandum, with participation from Visionaries Club and angel investors, including Charlie Songhurst (Meta Platforms board), Adam D’Angelo and Thomas Wolf (Hugging Face), and Erik Bernhardsson (Modal Labs).
Lawyers Kevin Rooney, Karem Jarada, Carl Min, Shelby Saunders, Rebecca Ross, Christopher Kimball and Karen Tsai led the Cooley team advising Lovable, with support from paralegal Chu Lee and transactional quantitative analyst Jake Ironfield.
Related contacts
Related Practices & Industries
Nuvation Bio Announces up to $250 Million Nondilutive Financings From Sagard Healthcare Partners
February 18, 2025
Cooley advised Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, on its nondilutive financings of up to $250 million with Sagard Healthcare Partners.